Navigation Links
National Patient Advocate Foundation's Annual Capitol Hill Briefing Focuses on Patient Access Barriers to Life-Saving Medicines Placed on Specialty Tiers by Commercial Insurance Plans and Medicare
Date:5/8/2013

appeared in the Journal of Managed Care Pharmacy found that oncology patients taking prescription medications with an out-of-pocket cost higher than $200 were at least three times more likely to choose not to fill their prescriptions as those with out-of-pocket costs of $100 or less.

Congressman David McKinley (R-WV), whose office was represented at the briefing, has put forth legislation to mitigate the numerous problems specialty tier drugs pose to patients. The Patient Access to Treatments Act (H.R. 460), co-sponsored by Representative Lois Capps (D-CA) and a bipartisan list of 38 other Members, aims to give millions of patients access to critical treatments that are currently out of their financial reach. Under this legislation, commercial insurers could not charge patients a percentage of the drug cost, but rather the same fixed co-payment they charge for other medications.

"A diagnosis of a debilitating disease is enough stress for patients and their families," McKinley stated. "Cutting-edge drug therapies should be made accessible to all patients regardless of their financial situation. The right to treatment and the highest quality of life possible while ill is not just for the wealthy."

NPAF has also developed a three-pronged strategy to combat the high out-of-pocket costs of specialty tiers. NPAF is working closely with Representative McKinley's office to increase awareness to H.R. 460 and with Senate staff to explore specialty tier solutions in Medicare. NPAF is also working with the Centers for Medicare and Medicaid Services to examine regulatory solutions to specialty tiers. Furthermore, NPAF is collaborating with the health insurance industry to create an open dialogue on solutions and agreements on specialty tiers outside the legislative and regulatory scope. By doing so, NPAF aims to understand the impact changes to health plan cost sharing would have on all
'/>"/>

SOURCE National Patient Advocate Foundation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Janssen and Johnson & Johnson to Provide Webcast Presentation of Simeprevir Phase 3 Clinical Data Presented at The International Liver Congress of the European Association for the Study of the Liver (EASL)
2. Assurance Biosense to Unveil Next-Generation Alar Sensor at the International Anesthesia Research Society Meeting
3. Vatsala Naageshwaran of Absorption Systems to Present at Disso 2013 International Conference in Mumbai, India on May 3rd
4. HeartWare International Reports $49.2 Million In First Quarter 2013 Revenue; 87% Increase From First Quarter Of 2012
5. Register by April 30th to get the Discounted Rate for Association of Bioscience Financial Officers (ABFO) 2013 National Conference - San Diego
6. National Association of Specialty Pharmacy (NASP) Appoints Thomas Blissenbach, RPh, MS as a Member of The Board of Directors
7. Lilly Celebrates National Volunteer Week with Deployment of Global Service Teams
8. Valeant Pharmaceuticals International, Inc. Completes Tender Offer for Obagi Medical Products, Inc.
9. Inhibikase Therapeutics to present at 5th International Congress on Polyomaviruses and Human Diseases
10. American Skin Association Announces New Member Of The Board J. Michael Pearson And New Education Council Member Ryan Weldon Of Valeant Pharmaceuticals International, Inc.
11. Musculoskeletal Network covers the Osteoarthritis Research Society International Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... May 26, 2015 For the ... Quality of Life Throughout Europe, the Middle ... Astellas Pharma EMEA is celebrating its 10 ... through the historic merger of Japanese pharmaceutical companies Yamanouchi ... committed to turning science into value for patients through ...
(Date:5/22/2015)... May 22, 2015  Research and Benchmarking firm, ... Medical Affairs Roundtable on Thursday, May ... virtual roundtable to discuss "Medical Affairs, Role in ... Practices, Medical Affairs Consortium provides Medical Affairs leaders ... key challenges they face. The consortium has developed ...
(Date:5/22/2015)... OAKS, Calif. , May 22, 2015 ... announced the Company has commenced termination of ... of brodalumab with AstraZeneca (LON:AZN, STO:AZN and ... IL-17 inhibitor, is in development for patients ... axial spondyloarthritis.  The decision was based on ...
Breaking Medicine Technology:Astellas Pharma EMEA Celebrates Its 10th Anniversary 2Astellas Pharma EMEA Celebrates Its 10th Anniversary 3Astellas Pharma EMEA Celebrates Its 10th Anniversary 4Best Practices Sixth Medical Affairs Consortium Roundtable to Focus on Health Economics & Outcomes Research 2Amgen to terminate participation in co-development and commercialization of brodalumab 2Amgen to terminate participation in co-development and commercialization of brodalumab 3Amgen to terminate participation in co-development and commercialization of brodalumab 4Amgen to terminate participation in co-development and commercialization of brodalumab 5
... The Pittsburgh Life Sciences Greenhouse (PLSG), ... formation and business growth programs to the region,s ... President and Chief Executive Officer, John W. ... signing an agreement with Ortho-McNeil-Janssen Pharmaceuticals, a Johnson ...
... Pa. , June 22 TheraQuest Biosciences, Inc., a ... TheraQuest also announced the launch of its new corporate website at ... , ... a careful strategic review of our pipeline, we have realigned our ...
Cached Medicine Technology:The Pittsburgh Life Sciences Greenhouse Congratulates Diamyd Medical on Its Agreement with Ortho-McNeil-Janssen Pharmaceuticals to Develop Diabetes Therapy 2TheraQuest Unveils New Pain Management Product Pipeline 2TheraQuest Unveils New Pain Management Product Pipeline 3TheraQuest Unveils New Pain Management Product Pipeline 4TheraQuest Unveils New Pain Management Product Pipeline 5
(Date:5/26/2015)... May 26, 2015 Hexagon Geospatial is ... Defence and Space in a new content-sharing program that ... for use in the development of smart applications. ... this partnership combines optical satellite data from Airbus Defence ... tear down the walls between geospatial content, software and ...
(Date:5/26/2015)... (PRWEB) May 26, 2015 i2i Systems, ... solutions for more than 15 years, has earned 2014 ... Committee for Quality Assurance (NCQA) for its flagship product ... are proud of the work we have done to ... grateful for the acknowledgement from NCQA once again,” said ...
(Date:5/26/2015)... 2015 Scientists at the University of ... help advanced mesothelioma patients benefit from immunotherapy; surgery may ... article on the new research. Click here to ... of thoracic surgery and pulmonology theorized that, because large ... system attack, immunotherapy drugs might work better if the ...
(Date:5/26/2015)... 2015 ProTrailer Network is a new ... Pro X . This Effect includes 30 all ... styled text. , ProTrailer Network allows users to ... can easily complement any form of media project. FCPX ... can make professional looking openers. , ProTrailer Network includes ...
(Date:5/26/2015)... 2015 Learning ZoneXpress is excited to ... Education Cards . These cards have been specifically designed ... simple, easy-to-read text, these new educational resources are extremely ... practical nutrition tips and suggestions to clients and provide ... , + MyPlate: Eat for a Healthy Baby Pregnancy ...
Breaking Medicine News(10 mins):Health News:Hexagon Geospatial and Airbus Defense Establish Partnership 2Health News:Hexagon Geospatial and Airbus Defense Establish Partnership 3Health News:i2iTracks Earns NCQA 2014 PCMH Prevalidation 2Health News:i2iTracks Earns NCQA 2014 PCMH Prevalidation 3Health News:Researchers Say Surgery May Restore Effectiveness of Immunotherapy for Mesothelioma, According to Surviving Mesothelioma 2Health News:Developers at Pixel Film Studios Release ProTrailer Network for Final Cut Pro X 2Health News:Learning ZoneXpress Introduces New Educational Resource for WIC, SNAP-Ed, and EFNEP 2
... a forewarning from severe periodontal disease than non-diabetic pregnant ... periodontology.// ,Researchers from the University of Iowa Colleges ... and 20 non-diabetic women in their 20-39th week of ... the control of diabetes. They found the diabetics flaunted ...
... men who eat up tomato products more than twice ... prostate cancer. Consuming cooked tomatoes was particularly beneficial, according ... sauce, ketchup and other tomato-based foods lowered the prostate ... ,Dr. Edward Giovannucci of Brigham and Women's Hospital and ...
... transplant patients contracted a dangerous parasitic disease from their ... women died, but only one recovered after antibiotic treatment.// ... Disease Control and Prevention turned up 26 bacterial infections ... in the United States. ,This shows that the ...
... medications than smokers, as the extra weight poses them ... the nation's principal cause of preventable deaths, the surgeon ... ,For a more precise look at the ... from two national health surveys to estimate inpatient and ...
... Getting cold out of doors condenses the blood and increases ... of University of Texas, it has been found that too ... - in Britain. He believes that cold temperatures alter the ... raises the risk of clotting and heart attack. ...
... gender were among the best indicators of how you might ... state-by-state study of prescription drug use, where you live also ... you use. // ,According to the study, the percentage ... ranged from a high of 71 percent in Kansas to ...
Cached Medicine News:Health News:Prescription Drug Use Varies Widely Between States 2
Part of the Octopus System which includes both the Starfish & Octopus3. The Octopus3 Tissue Stabilizer is the pioneering and market-leading suction device....
... way to lift the heart - Guidant's ... 3. The XPOSE 3 is designed to ... surgery and to easily position and access ... both apical and non-apical placement on the ...
... The CLEARGLIDE Optical Vessel Dissector has application ... operative cavity in the extraperitoneal spaces such ... The device may be used in surgical ... EVH system enables harvesting of a quality ...
The MicroMed DeBakey VAD is a miniaturized heart pump designed to provide increased blood flow (up to 10L/min) from the left ventricle of the heart throughout the body for patients in end stage heart...
Medicine Products: